Schlesinger Sarah J.
SEC insider (Form 3/4/5 filer). CIK 0001579873. Director at Innoviva, Inc. (INVA) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on May 4, 2026. Located in LOS ANGELES, CA.
Companies Schlesinger Sarah J. has filed insider reports for
- Innoviva, Inc. (INVA): Director
- Armata Pharmaceuticals, Inc. (ARMP): Director
Schlesinger Sarah J.
CIK: 0001579873
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)4 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- May 4, 2026INVA
Innoviva, Inc.
AwardDirect9.8K shares- - Mar 9, 2026ARMP
Armata Pharmaceuticals, Inc.
AwardDirectStock Options (Right to Buy)
25.6K shares- - May 19, 2025INVA
Innoviva, Inc.
AwardDirect12.1K shares- - Feb 5, 2025ARMP
Armata Pharmaceuticals, Inc.
AwardDirectStock Options (Right to Buy)
54.3K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| May 4, 2026 |  INVA Innoviva, Inc. | Award | 9,786 | - | $0 | Direct |
| Mar 9, 2026 |  ARMP Armata Pharmaceuticals, Inc. | Award Stock Options (Right to Buy) | 25,640 | - | - | Direct |
| May 19, 2025 | INVA Innoviva, Inc. | Award | 12,077 | - | - | Direct |
| Feb 5, 2025 | ARMP Armata Pharmaceuticals, Inc. | Award Stock Options (Right to Buy) | 54,343 | - | - | Direct |
1-4 of 4 transactions